Update on systemic therapy of advanced non-small-cell lung cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737140.2014.940327
Reference99 articles.
1. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2. Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years
3. Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies
4. New driver mutations in non-small-cell lung cancer
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An advanced IVB lung adenocarcinoma patient with KRAS mutations, benefited from camrelizumab combined with anti- angiogenic agents for therapy: a case report;2024-01-22
2. REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR RESISTANCE VIA AMBRA1-MEDIATED AUTOPHAGY IN NON-SMALL CELL LUNG CANCER;J PHYSIOL PHARMACOL;2023
3. Overexpression of DAPK1 and Beclin1 under oxygen and glucose deprivation conditions promotes excessive autophagy and apoptosis in A549 cells;MedComm – Oncology;2023-04-26
4. AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer;PLOS ONE;2022-12-15
5. Chemopreventive role of Tin oxide-Chitosan-Polyethylene glycol-Crocin nanocomposites against Lung cancer: An in vitro and in vivo approach;Process Biochemistry;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3